Sperm tests provide a direct and effective way of identifying chemical agents that induce spermatogenic damage in man. Four human sperm tests are available: sperm count, motility, morphology (seminal cytology) and the Y-body test. These sperm tests have numerous advantages over other approaches for assessing spermatogenic damage, and they have already been used to assess the effects of at least 85 different occupational, environmental, and drug-related chemical exposures. When carefully controlled, seminal cytology appears to be statistically more sensitive than the other human sperm tests and should be considered an integral part of semen analysis when assessing induced spermatogenic damage.
Introduction
Studies with numerous chemical agents in a variety of mammalian species have shown that sperm anomalies can be used as indicators, and in certain instances, as dosimeters ofchemically induced spermatogenic damage (1, 2) . Various other approaches have also been proposed to assess chemically induced spermatogenic dysfunction including testicular biopsies (3), questionnaire surveys (4) and blood levels of gonadotrophins (5) . Sperm tests have the advantage that they are noninvasive, generally less expensive, require smaller sample sizes, and are sensitive to small changes (1, 2, 5) .
A recent survey of the literature (2) showed that sperm tests have been more widely used to assess *Lawrence Livermore National Laboratory, Biomedical Sciences Division, Unversity of California, Livermore, CA 94550. the effects of chemical exposures in man than was generally suspected; more than 100 papers involving some 85 different chemical exposures have been published. This paper briefly describes the methods and applications of the four most common human sperm tests, compares their relative sensitivities and suggests guidelines for undertaking a new human sperm study in men exposed to toxic agents. The paper also discusses the role of animal studies, the implication of semen findings for reproductive outcome, and future research needs in these areas.
Description of Human Sperm Tests
Human semen tests have a long history in the diagnosis of infertility (5) . Thus, it is not surprising that the early attempts to assess altered spermatogenic function in men exposed to chemicals involved measuring changes in the sperm parameters commonly used in fertility diagnosis, such as sperm density (counts), motility, and morphology (seminal cytology). The following is a very brief description of these methods.
Sperm count is usually reported as the number of sperm per milliliter of ejaculate (or as the total number of sperm ejaculated) as determined by hemocytometer (6) . The measurement is technically easy, and automated methods are also available. However, interpretation of results may be confounded by a number of factors, such as variable continence time before ejaculation and collection of an incomplete ejaculate (7).
Sperm motility is the swimming ability of the sperm and has been expressed in a large variety of ways (6) . Although motility may be one of the best performance evaluations of spermatogenic function in relation to fertility, it is also very sensitive to time and temperature after collection (8) . Thus, semen motility is very difficult to measure in a field study, especially when samples are collected at home. Considerable emphasis has been put on automated and quantitative methods for assessing sperm motility (9) .
Sperm morphology (also referred to as seminal cytology) is the visual assessment of the shapes of ejaculated sperm. Although sperm-head shape is usually emphasized, some assessments also incorporate midpiece and tail abnormalities. In general, there has been little agreement in the definition of normal shapes or in the categories of abnormal shapes. This has resulted in much interlaboratory and interscorer variability (10, 11) . However, studies of MacLeod (12), David et al. (13) , Eliasson (14) , and others have shown that quantitative approaches to the visual assessment of morphology can be used with considerably success. These assessments are usually made by using smears that are air-dried, fixed and stained with a Papanicolaou method (15) . Sperm can be systematically assigned to shape categories. In evaluating the effects of exposure, slides of controls should be concurrently analyzed with slides of exposed men in a blindstudy design. Normal ranges have been established for several unexposed populations.
We have developed a human morphology test by describing 10 classes of sperm-head shapes (16, 17) and classifying 500 sperm per individual. Through the intermittent use of coded standard slides, we have been able to assure constancy in the visual scoring criteria for sperm morphology over a period of many years. Our experience with this test shows that visual scoring criteria can be very objective (unpublished data). We have applied this method to men occupationally exposed to carbaryl (17) and anesthetic gases (16) . The carbaryl workers showed higher proportions of sperm with shape abnormalities than controls but no dose response was observed and there was no difference in sperm counts. No effects of anesthetic gases on sperm were observed. In another study, men exposed to cancerchemotherapeutic agents showed drug-related decreases in sperm counts and increases in sperm-shape abnormalities (18) .
The Y-body test scores the frequency offluorescent spots in human sperm stained with quinacrine dye. Based on studies in somatic cells, it is thought that these spots represent Y chromosomes (19) . The Y-body test scores the frequency of sperm with two spots, which are thought to represent sperm with 2 Y chromosomes due to meiotic nondisjunction (20) . Unlike the other sperm tests (counts, motility, and morphology), the Y-body test has no direct counterpart in the mouse or other common laboratory animals. The Y-chromosomal fluorescence after quinacrine staining seems to be unique to man and certain apes (21) . However, it should be noted that the field vole, Microtus oeconomus, has a unique distribution of heterochromatin, which allows visualization of the X and Y chromosome in spermatids and possibly testicular sperm (22) . Studies with several chemical agents suggest that this system may be a useful animal model for studying the induction of sex-chromosomal nondisjunction in male germ cells.
For the analysis of Y-bodies in human sperm, air-dried smears can be fixed, stained and sperm scored under a fluorescent microscope (19, 20) . The number of sperm scored depends on the statistical precision required. Each sperm is scored as OY (containing no fluorescent body, presumably sperm with no Y chromosome), 1Y (those sperm presumably containing one Y chromosome) and 2Y (sperm presumably containing two Y chromosomes). We have developed the method so that we can repeatedly visualize approximately 50% of the sperm with a single fluorescent body (unpublished data). The Y-body test is very new, its relationship to chromosomal aneuploidy uncertain and only a few populations of exposed men have been analyzed (2).
Applications of Human Sperm Tests
The above methods have been applied to assess spermatogenic function in at least 85 different groups of chemically exposed men (2) . Tables 1-4 categorize these agents into occupational and environmental chemicals (Table 1) , experimental and therapeutic drugs (Tables 2 and 3) , and recreational drug use (Table 4) . Details of the studies surveyed to generate these tables and the decision criteria used to classify each agent as one with adverse effects, suggestive of adverse effects or with no apparent adverse effects are published elsewhere (2) . Several agents (not listed in these tables) have been reported to improve sperm quality in some cases (2 Glycerine production compounds Lead Polybrominated biphenyls Toluenediamine + dinitrotoluene aTable entries are based on studies of sperm counts, motility, morphology and double Y-bodies. The assignment of individual agents to columns is based on the data provided in the papers reviewed by the Human Sperm Reviewing Committee of the U.S. Environmental Protection Agency (EPA) GENE-TOX Program (2). These entries are generally based on few studies and may be expected to change as more data become available. (2) . These entries are generally based on few studies and may be expected to change as more data become available. When considering sperm studies several study designs are possible. Since between-male variability in semen characteristics is high even among fertile and presumably healthy men, rather large numbers of cooperative subjects are required to establish differences between control and exposed groups in cross-sectional studies (each individual sampled only once). Longitudinal study designs may be more appropriate when fewer men are available for sampling. In this study design, repeated semen samples are collected from each man at different times in relation to the time of exposure and compared to assess chemically induced sperm defects. Since variation of sperm morphology within an individual is considerably less than variation among individuals (23) , in principle, fewer people are required for induced changes to be detected. These studies, however, have some constraints: repeated samplings during a period of months and perhaps years are required; samples before exposure are needed (or within days of an acute exposure before any induced effects on morphology are seen); and the number of men needed for an effective study is unknown.
The effects of age, smoking, illness, medication, and other possibly confounding factors, especially those involving heat exposure, must be considered in the analysis of all human sperm data.
Possible Roles for Animal Tests
The availability of both animal and human sperm tests suggests several applications of animal studies in the assessment of chemically induced spermatotoxicity, antifertility effects, and heritable genetic abnormalities in man. First, animal sperm tests (such as mouse morphology) may be used to screen large numbers of agents to establish a ranking that sets priorities for identifying exposed men. Second, animal sperm studies may also be useful in evaluating an agent or the components of a complex mixture that are suspected of affecting human sperm (such as in an occupational or environmental exposure). Third, animal breeding tests may be used to study the relationship between changes in sperm parameters, fertility changes, and heritable consequences.
Since little is known of the quantitative relationships between induced sperm abnormalities and heritable genetic damage, indirect methods may be needed to assess the genetic risk to offspring of men who show induced sperm anomalies. By combining data from short-term mutagen bioassays (e.g., Salmonella/microsome assay, mammalian somatic cell mutation assays), which may demonstrate mutagenic potential, with data from animal and human sperm tests, which may demonstrate activity in the testes, we may be able to evaluate whether or not a mutagen is active in the testes. Further studies are needed to investigate this approach.
Genetic Implications of Chemically Induced Sperm Defects Evidence from Human Studies
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